Compounds > aztreonam

aztreonam and fosfomycin

aztreonam has been researched along with fosfomycin in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (15.00)18.2507
2000's4 (20.00)29.6817
2010's10 (50.00)24.3611
2020's3 (15.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Kuzui, H; Murakami, T; Nishino, T; Obana, Y1
Hirano, J; Hirano, K; Imamura, A; Ishii, N; Kakizaki, H; Mitobe, K; Murakami, S; Saito, M; Suzuki, K; Takamizawa, A1
Nieto, E; Soriano, F; Zapardiel, J1
Guerin, F; Henegar, C; Launay, O; Poyart, C; Salmon-Ceron, D; Spiridon, G1
Lipp, HP1
Cars, O; Cars, T; Hickman, RA; Hughes, D; Malmberg, C1
Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T1
Cole, NC; Cunningham, SA; De, PP; Harris, KA; Koh, TH; Kohner, PC; Krause, KM; Menon, SR; Patel, R; Vasoo, S1
Barros, EM; Barth, AL; Campos, JC; Cerdeira, LT; da Silva, MJ; de Faria-Júnior, C; de Oliveira, TG; dos Santos, PR; Leiroz, LK; Magagnin, CM; Pereira, Mde O; Poirel, L; Sampaio, JL; Sampaio, SC; Seco, BM; Zavascki, AP1
Cayô, R; Cuba, GT; Gales, AC; Kiffer, CRV; Nicolau, DP; Nodari, CS; Pignatari, ACC; Rocha-Santos, G; Streling, AP1
Ashraf, T; Barathan, G; Darwish, D; Ghazawi, A; Hashmey, R; Pál, T; Rizvi, TA; Sonnevend, Á1
Al-Farsi, H; Allander, L; Lagerbäck, P; Olsson, A; Shams, A; Tängdén, T1

Reviews

2 review(s) available for aztreonam and fosfomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Revival of selected well-tried antibiotics. Special features of the antiinfective agents penicillin G, fosfomycin, aztreonam and colistin].
    Medizinische Monatsschrift fur Pharmazeuten, 2012, Volume: 35, Issue:10

    Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Colistin; Fosfomycin; Humans; Kidney Diseases; Penicillin G

2012

Trials

1 trial(s) available for aztreonam and fosfomycin

ArticleYear
[Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
    Hinyokika kiyo. Acta urologica Japonica, 1990, Volume: 36, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Chronic Disease; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Middle Aged; Urinary Tract Infections

1990

Other Studies

17 other study(ies) available for aztreonam and fosfomycin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
[Bacterial combination effect between carumonam and eight other antibiotics].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:12

    Topics: Animals; Aztreonam; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Female; Fosfomycin; Gentamicins; Mice; Piperacillin; Proteus vulgaris; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections

1990
Evaluation of a new selective medium for the isolation of Corynebacterium urealyticum.
    Journal of medical microbiology, 1998, Volume: 47, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteriuria; Colony Count, Microbial; Corynebacterium; Corynebacterium Infections; Culture Media; Drug Resistance, Microbial; Evaluation Studies as Topic; Fosfomycin; Humans; Microbial Sensitivity Tests; Monobactams; Polymyxin B; Skin

1998
Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cryptococcosis; Cryptococcus neoformans; Fosfomycin; HIV Seropositivity; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prostatitis; Pseudomonas aeruginosa; Pseudomonas Infections; Saudi Arabia

2005
Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:4

    Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; Cell Wall; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; Fosfomycin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests

2014
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin

2014
In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Ceftazidime; Colistin; Drug Combinations; Enterobacteriaceae; Fosfomycin; Gene Expression; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline

2015
Characterization of Tn3000, a Transposon Responsible for blaNDM-1 Dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Brazil; Conjugation, Genetic; Conserved Sequence; DNA Transposable Elements; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Fosfomycin; Humans; India; Microbial Sensitivity Tests; Morocco; Nepal; Plasmids; Rectum

2015
In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2020, 07-01, Volume: 75, Issue:7

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2020
In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Bacterial; Fosfomycin; Humans; Microbial Sensitivity Tests; Middle East; Tigecycline

2020
Activity of polymyxin B combinations against genetically well-characterised Klebsiella pneumoniae producing NDM-1 and OXA-48-like carbapenemases.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:5

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Drug Synergism; Fosfomycin; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Polymyxin B; Rifampin

2023